| Cat. No. |
Product |
Quantity/Size |
Price |
Data |
|
| MVV00803A |
Anti-SARS-CoV-2 NP/Nucleoprotein Monoclonal Antibody (1A164) |
50 µg |
$275.00
|
 |
BUY
|
| MVV00803B |
Anti-SARS-CoV-2 NP/Nucleoprotein Monoclonal Antibody (1A164) |
100 µg |
$395.00
|
|
BUY
|
| MVV00804A |
Anti-SARS-CoV-2 NP/Nucleoprotein Monoclonal Antibody (1A165) |
50 µg |
$275.00
|
|
BUY
|
| MVV00804B |
Anti-SARS-CoV-2 NP/Nucleoprotein Monoclonal Antibody (1A165) |
100 µg |
$395.00
|
|
BUY
|
| MVV00303B |
Anti-SARS-CoV-2 RBD Monoclonal Antibody (1A162) |
100 µg |
$395.00
|
|
BUY
|
| MVV00303A |
Anti-SARS-CoV-2 RBD Monoclonal Antibody (1A162) |
50 µg |
$275.00
|
|
BUY
|
| MVV00304B |
Anti-SARS-CoV-2 RBD Monoclonal Antibody (1A163) |
100 µg |
$395.00
|
|
BUY
|
| MVV00304A |
Anti-SARS-CoV-2 RBD Monoclonal Antibody (1A163) |
50 µg |
$275.00
|
|
BUY
|
| MVV00102A |
Anti-SARS-CoV-2 S Protein Monoclonal Antibody (1A159) |
50 µg |
$275.00
|
|
BUY
|
| MVV00102B |
Anti-SARS-CoV-2 S Protein Monoclonal Antibody (1A159) |
100 µg |
$395.00
|
|
BUY
|
| MVV00503A |
Anti-SARS-CoV-2 S2 Protein Monoclonal Antibody (1A160) |
50 µg |
$275.00
|
|
BUY
|
| MVV00503B |
Anti-SARS-CoV-2 S2 Protein Monoclonal Antibody (1A160) |
100 µg |
$395.00
|
|
BUY
|
| MVV00504A |
Anti-SARS-CoV-2 S2 Protein Monoclonal Antibody (1A161) |
50 µg |
$275.00
|
|
BUY
|
| MVV00504B |
Anti-SARS-CoV-2 S2 Protein Monoclonal Antibody (1A161) |
100 µg |
$395.00
|
|
BUY
|
| RVV00201A |
Anti-SARS-CoV-2 Spike-NTD (4A8) Neutralizing mAb |
100µg |
$390.00
|
|
BUY
|
| RVV00201B |
Anti-SARS-CoV-2 Spike-NTD (4A8) Neutralizing mAb |
1mg |
$1,710.00
|
|
BUY
|
| CPC534A |
Human Anti-SARS-CoV-2 Spike-RBD Bamlanivimab (LY-CoV555）Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC534B |
Human Anti-SARS-CoV-2 Spike-RBD Bamlanivimab (LY-CoV555）Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC538B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike Glycoprotein Sotrovimab (VIR-7831 / GSK4182136) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC538A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike Glycoprotein Sotrovimab (VIR-7831 / GSK4182136) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC524A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike S1 Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC524B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike S1 Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC530B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike S2, Clone AbF712, mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC530A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike S2, Clone AbF712, mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC531B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike S2, Clone AbH722, mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC531A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike S2, Clone AbH722, mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC535A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike-RBD Cilgavimab (AZD1061) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC535B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike-RBD Cilgavimab (AZD1061) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC537B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike-RBD Tixagevimab (AZD8895) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC537A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike-RBD Tixagevimab (AZD8895) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC517B |
Human Anti-SARS-CoV-2 Nucleocapsid (AbD207) mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC517A |
Human Anti-SARS-CoV-2 Nucleocapsid (AbD207) mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC518A |
Human Anti-SARS-CoV-2 Nucleocapsid (AbG733) mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC518B |
Human Anti-SARS-CoV-2 Nucleocapsid (AbG733) mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC522B |
Human Anti-SARS-CoV-2 Spike RBD (B38) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC523A |
Human Anti-SARS-CoV-2 Spike RBD (B38) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC522A |
Human Anti-SARS-CoV-2 Spike RBD (B38) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC523B |
Human Anti-SARS-CoV-2 Spike RBD (B38) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC521B |
Human Anti-SARS-CoV-2 Spike RBD (H4) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC521A |
Human Anti-SARS-CoV-2 Spike RBD (H4) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC520A |
Human Anti-SARS-CoV-2 Spike S1 (CR3022) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC520B |
Human Anti-SARS-CoV-2 Spike S1 (CR3022) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC514C |
Human Anti-SARS-CoV-2 Spike-NTD (4A8) Neutralizing mAb |
1.0 mg |
Please Inquire |
|
BUY
|
| CPC514B |
Human Anti-SARS-CoV-2 Spike-NTD (4A8) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC526B |
Human Anti-SARS-CoV-2 Spike-RBD (Clone AbG123) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC526A |
Human Anti-SARS-CoV-2 Spike-RBD (Clone AbG123) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC510B |
Human Anti-SARS-CoV-2 Spike-RBD (Clone VHH-72-Fc) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC510A |
Human Anti-SARS-CoV-2 Spike-RBD (Clone VHH-72-Fc) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC513B |
Human Anti-SARS-CoV-2 Spike-RBD (EY6A) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC513A |
Human Anti-SARS-CoV-2 Spike-RBD (EY6A) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC525A |
Human Anti-SARS-CoV-2 Spike-RBD (S309) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC525B |
Human Anti-SARS-CoV-2 Spike-RBD (S309) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC539A |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC539B |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC511A |
Human Anti-SARS-CoV-2 Spike-RBD Casirivimab(REGN10933) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC511B |
Human Anti-SARS-CoV-2 Spike-RBD Casirivimab(REGN10933) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC516B |
Human Anti-SARS-CoV-2 Spike-RBD Etesevimab (CB6, JS016, LY-CoV-016) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC516A |
Human Anti-SARS-CoV-2 Spike-RBD Etesevimab (CB6, JS016, LY-CoV-016) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC512B |
Human Anti-SARS-CoV-2 Spike-RBD Imdevimab (REGN10987) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC541C |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
1.0 mg |
Please Inquire |
|
BUY
|
| CPC541A |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC541B |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC532A |
Mouse Anti-Human ACE2, mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC532B |
Mouse Anti-Human ACE2, mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC519A |
Mouse Anti-SARS-CoV-2 Spike S1 (CR3022) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC519B |
Mouse Anti-SARS-CoV-2 Spike S1 (CR3022) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
